However, it remains unknown whether GDF15 contributes to muscle weakness, fatigue and exercise intolerance in mitochondrial myopathy and whether GDF15 blockade could be a potential therapy for PMM. This evidence concerns the gene GDF15 and Mitochondrial myopathy.